Clinical trial
Characterisation of the Immune Response to SARS-CoV-2 and Other Common Infections in Type 1 Diabetes
NCT05171998 is registered in ClinicalTrials.gov with Cwm Taf University Health Board (NHS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterisation of the Immune Response to SARS-CoV-2 and Other Common Infections in Type 1 Diabetes
- Lead sponsor
- Cwm Taf University Health Board (NHS)
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- July 1, 2024
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 1, sars-cov2 infection common pathogens